Probiotics alleviate oral microbiota disruptions induced by Helicobacter pylori eradication with vonoprazan-amoxicillin dual therapy: a randomized double-blind placebo-controlled trial. (An exploratory study)
BackgroundHelicobacter pylori (H. pylori) infection affects approximately half of the global population and has been linked to oral microbiota dysbiosis, while eradication therapies may further disrupt microbial balance. This exploratory study investigated the effects of H. pylori infection, 14-day...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-05-01
|
| Col·lecció: | Frontiers in Cellular and Infection Microbiology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fcimb.2026.1740968/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|